US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

25.14

-1.3200-4.99%

Post-market: 25.140.00000.00%16:10 EST

Volume:58.00K

Turnover:1.40M

Market Cap:76.97M

PE:-1.69

High:26.95

Open:26.67

Low:21.61

Close:26.46

52wk High:54.29

52wk Low:5.51

Shares:3.06M

Float Shares:2.62M

Volume Ratio:2.20

T/O Rate:2.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-14.8358

EPS(LYR):-14.2710

ROE:-83.00%

ROA:-20.64%

PB:1.32

PE(LYR):-1.76

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Pelthos Therapeutics Director Ezra M. Friedberg Sells Common Shares

Pelthos Therapeutics (PTHS) Gets a Buy from Roth MKM

Pelthos Therapeutics Inc. Announces Date for Upcoming Annual Shareholder Meeting

Pelthos Therapeutics reports $7.4 million in third quarter revenue

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PTHS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTHS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","market":"US","secType":"STK","nameCN":"PELTHOS THERAPEUTICS INC","latestPrice":25.14,"timestamp":1764709200000,"preClose":26.46,"halted":0,"volume":57995,"hourTrading":{"tag":"盘后","latestPrice":25.14,"preClose":25.14,"latestTime":"16:10 EST","volume":5,"amount":125.7,"timestamp":1764709804873},"delay":0,"floatShares":2623100,"shares":3061681,"eps":-14.835798,"marketStatus":"Post-Mkt","change":-1.32,"latestTime":"12-02 17:16:31 EST","open":26.67,"high":26.95,"low":21.61,"amount":1401813.7146,"amplitude":0.201814,"askPrice":35.81,"askSize":100,"bidPrice":24.65,"bidSize":51,"shortable":0,"etf":0,"ttmEps":-14.835798,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"listingDate":1708059600000,"exchange":"AMEX","adjPreClose":26.46,"preHourTrading":{"tag":"盘前","latestPrice":27.49,"preClose":26.46,"latestTime":"09:28 EST","volume":6,"amount":164.95000199999998,"timestamp":1764685737598},"postHourTrading":{"tag":"盘后","latestPrice":25.14,"preClose":25.14,"latestTime":"16:10 EST","volume":5,"amount":125.7,"timestamp":1764709804873},"volumeRatio":2.19688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTHS\",,,,,undefined,":{"symbol":"PTHS","floatShares":2623100,"roa":"-20.64%","roe":"-83.00%","lyrEps":-14.271021,"volumeRatio":2.19688,"shares":3061681,"dividePrice":0,"high":26.95,"amplitude":0.201814,"preClose":26.46,"low":21.61,"week52Low":5.513,"pbRate":"1.32","psRate":"10.39","week52High":54.29,"institutionHeld":0,"latestPrice":25.14,"committee":-0.324503,"eps":-14.835798,"divideRate":0,"volume":57995,"delay":0,"ttmEps":-14.835798,"open":26.67,"prevYearClose":6.41,"prevWeekClose":28.4,"prevMonthClose":28.4,"prevQuarterClose":28,"fiveDayClose":27.53,"twentyDayClose":34.21,"sixtyDayClose":32.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTHS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PTHS","fiscalQuarterEnding":"2025/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-5.3},{"market":"US","date":"2025-07-02","symbol":"PTHS","defaultRemindTime":1751463000000,"type":"split","dateTimestamp":1751428800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTHS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTHS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1764306000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTHS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTHS","date":"2025-12-01","current":-1.783524,"percent":0.580952,"low":-12.702408,"twenty":-11.1077,"median":-7.894967,"eighty":-1.793992,"high":-1.189404,"avg":-6.564203,"sd":4.26405,"marketCap":86951740},"quantilePoints":[{"date":"2025-07-03","current":-1.450338,"twenty":-1.398151,"median":-1.319871,"eighty":-1.241591,"marketCap":10675383},{"date":"2025-07-11","current":-2.372872,"twenty":-2.216593,"median":-1.475876,"eighty":-1.450338,"marketCap":17465810},{"date":"2025-07-18","current":-1.983069,"twenty":-1.968731,"median":-1.794665,"eighty":-1.455446,"marketCap":14596616},{"date":"2025-07-25","current":-1.97142,"twenty":-1.96909,"median":-1.819083,"eighty":-1.509032,"marketCap":14510870},{"date":"2025-08-01","current":-1.895251,"twenty":-1.972137,"median":-1.894355,"eighty":-1.668896,"marketCap":13950222},{"date":"2025-08-08","current":-1.785927,"twenty":-1.971241,"median":-1.88181,"eighty":-1.778579,"marketCap":13145529},{"date":"2025-08-15","current":-1.383693,"twenty":-1.968373,"median":-1.828044,"eighty":-1.653842,"marketCap":12505731},{"date":"2025-08-22","current":-1.565412,"twenty":-1.958336,"median":-1.793992,"eighty":-1.534031,"marketCap":14148098},{"date":"2025-08-29","current":-7.738365,"twenty":-1.968373,"median":-1.78996,"eighty":-1.553735,"marketCap":69938867},{"date":"2025-09-05","current":-10.936036,"twenty":-1.983069,"median":-1.813483,"eighty":-1.562493,"marketCap":98839226},{"date":"2025-09-12","current":-10.771103,"twenty":-7.559968,"median":-1.868816,"eighty":-1.565412,"marketCap":97348576},{"date":"2025-09-19","current":-11.212045,"twenty":-9.357396,"median":-1.887634,"eighty":-1.641655,"marketCap":101333783},{"date":"2025-09-26","current":-11.188484,"twenty":-10.771103,"median":-1.911381,"eighty":-1.642041,"marketCap":101120833},{"date":"2025-10-03","current":-8.961188,"twenty":-10.771103,"median":-1.965147,"eighty":-1.648609,"marketCap":80990668},{"date":"2025-10-10","current":-8.414925,"twenty":-10.626367,"median":-1.972316,"eighty":-1.659169,"marketCap":76053575},{"date":"2025-10-17","current":-9.593014,"twenty":-10.434506,"median":-2.154672,"eighty":-1.70259,"marketCap":86701075},{"date":"2025-10-24","current":-11.663085,"twenty":-10.626367,"median":-7.559968,"eighty":-1.70259,"marketCap":105410254},{"date":"2025-10-31","current":-11.19185,"twenty":-10.777835,"median":-7.80905,"eighty":-1.706174,"marketCap":101151254},{"date":"2025-11-07","current":-12.702408,"twenty":-10.936036,"median":-7.98408,"eighty":-1.777862,"marketCap":114803587},{"date":"2025-11-14","current":-11.772301,"twenty":-11.111066,"median":-8.995487,"eighty":-1.781447,"marketCap":106397338},{"date":"2025-11-21","current":-3.765213,"twenty":-11.111066,"median":-8.414925,"eighty":-1.785927,"marketCap":88788749},{"date":"2025-11-28","current":-3.687312,"twenty":-11.108373,"median":-7.960687,"eighty":-1.792379,"marketCap":86951740},{"date":"2025-12-01","current":-3.687312,"twenty":-11.1077,"median":-7.894967,"eighty":-1.793992,"marketCap":86951740}],"updateTime":1764677312727},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTHS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586261442","title":"Pelthos Therapeutics Director Ezra M. Friedberg Sells Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586261442","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586261442?lang=en_us&edition=fundamental","pubTime":"2025-11-27 01:37","pubTimestamp":1764178661,"startTime":"0","endTime":"0","summary":"Ezra M. Friedberg, a Director of Pelthos Therapeutics Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL3y2sTb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pelthos Therapeutics Director Ezra M. Friedberg Sells Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTHS","BK4139"],"gpt_icon":0},{"id":"2586449447","title":"Pelthos Therapeutics (PTHS) Gets a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2586449447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586449447?lang=en_us&edition=fundamental","pubTime":"2025-11-25 13:35","pubTimestamp":1764048915,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics received a Buy rating and a $57.00 price target from Roth MKM analyst Jonathan Aschoff today. According to TipRanks, Aschoff i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pelthos-therapeutics-pths-gets-a-buy-from-roth-mkm-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTHS"],"gpt_icon":0},{"id":"2583682180","title":"Pelthos Therapeutics Inc. Announces Date for Upcoming Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2583682180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583682180?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:50","pubTimestamp":1763157043,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc. has announced that it will hold its 2025 Annual Meeting of Shareholders online on December 17, 2025. Shareholders will have the opportunity to consider and vote on several items during the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pelthos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL8Gy4Nj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"gpt_icon":0},{"id":"2583356458","title":"Pelthos Therapeutics reports $7.4 million in third quarter revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2583356458","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583356458?lang=en_us&edition=fundamental","pubTime":"2025-11-13 19:50","pubTimestamp":1763034644,"startTime":"0","endTime":"0","summary":"Pelthos Therapeutics Inc. reported total revenue of $7.4 million for the third quarter ended September 30, 2025, compared to no revenue in the same period of 2024. Net product revenues from the commercial launch of ZELSUVMI, its FDA-approved at-home treatment for molluscum contagiosum, were $7.1 million, while license and collaboration revenues were $0.3 million. The company reported a net loss of $16.2 million, or $5.30 per basic and fully diluted common share. Cash and cash equivalents increased to $14.2 million as of September 30, 2025, from $0.5 million at the end of 2024, following a $50.1 million equity private placement. During the quarter, 2,716 units of ZELSUVMI were dispensed by 1,169 unique prescribers. The merger of Channel Therapeutics Corporation and LNHC, Inc. was completed to form Pelthos Therapeutics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL1kt5HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PTHS"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PTHS\",params:#limit:6,delay:false,,,undefined,":[]}}